BBR has been shown to improve lung inflammation in influenza mice by inhibiting NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome activation and inhibiting GSDMD-mediated apoptosis by reducing GSDMD expression and suppressing NLRP3 inflammasome-mediated GSDMD activation. Here, NLRP3 is linked to influenza.